Glp3

What is Retatrutide (GLP-3)?

Retatrutide is an advanced triple-agonist peptide that targets GLP-1, GIP, and glucagon receptors in the body. It is often called “GLP-3” because it works on three metabolic pathways at once. This mechanism helps regulate appetite, blood sugar, and fat metabolism simultaneously.

Research studies show it has strong potential for weight management and metabolic improvement, with significant results seen in clinical trials.

Note: It is still an investigational compound (not FDA approved) and is commonly labeled “for research purposes only.”

Available Variations
10 mg
Suitable for early-stage or lower-dose research
Often aligned with initial or moderate study ranges
Helps evaluate tolerance and baseline metabolic response
20 mg
Used for mid-level research protocols
Represents a stronger concentration for studying enhanced effects
Commonly explored where dose-dependent outcomes are required
30 mg
High-concentration option for advanced research use
Designed for maximum potency studies
Useful for observing strong metabolic and fat-loss responses
Key Research Insights
Typically studied as a once-weekly injectable peptide
Effects are dose-dependent, with higher doses showing stronger results
Works by reducing appetite, improving insulin response, and increasing energy expenditure